Share Issue/Capital Change • Feb 20, 2023
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
Disclosure 428537
Optomed PlcStock Exchange Release20 February 2023 at 16:00, Helsinki Change in Optomed's holding of treasury A total of 1,000 of shares have been subscribed for under the Company's stock option plan 2018C. Optomed has used treasury shares for the share subscriptions. The subscribed shares have been delivered to the subscribers on 20 February 2023. The total amount of treasury shares is now 373 566. Optomed Plc Further enquiries Sakari Knuutti, Chief Financial Officer, Optomed Plc, [email protected] Optomed in Brief Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.